Community post

News: LyseNTech, a Korean phage company led by Heejoon Myung, was named a leading research institute by the Korean Ministry of Trade, Industry and Energy. LyseNTech aims to develop 'LNT103', a phage-derived endolysin, as an inhaled treatment through a nebulizer.